3-iodobenzylguanidine has been researched along with Heart Failure, Systolic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, JC; Carestiato, LR; Felix, RM; Mesquita, CT; Mesquita, ET; Messias, LR; Miranda, SM; Moscavitch, SD; Nóbrega, AC; Rodrigues, RC | 1 |
| Aggarwal, H; Ahmed, A; Chen, J; Hage, FG; Heo, J; Iskandrian, AE; Jacobson, AF; Patel, K | 1 |
| Fukunami, M; Hori, M; Iwasaki, Y; Masuda, M; Morita, T; Okuda, K; Okuyama, Y; Sanada, S; Tamaki, S; Tsukamoto, Y; Yamada, T; Yasui, T | 1 |
| Almenar-Bonet, L; Cano-Pérez, O; Martínez-Dolz, L; Navarro-Mateo, A; Ruiz-Llorca, C; Sánchez-Lázaro, IJ; Sancho-Tello, MJ; Sanz, AS | 1 |
| Azevedo, JC; Barbirato, GB; Coimbra, A; Dohmann, HF; Freire, Fde L; Mesquita, CT; Mesquita, ET; Miranda, SM; Nóbrega, AC; Ribeiro, ML | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Heart Failure, Systolic
| Article | Year |
|---|---|
The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; Death, Sudden, Cardiac; Female; Follow-Up Studies; Heart; Heart Failure, Systolic; Heart Ventricles; Humans; Male; Middle Aged; Neurons; Perfusion; Prognosis; Software; Sympathetic Nervous System; Technetium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2014 |
4 other study(ies) available for 3-iodobenzylguanidine and Heart Failure, Systolic
| Article | Year |
|---|---|
Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stroke Volume | 2013 |
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with si
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; Heart Failure, Systolic; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2009 |
Autonomic nervous system dysfunction in advanced systolic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Electrocardiography, Ambulatory; Female; Heart Failure, Systolic; Heart Rate; Humans; Male; Middle Aged; Models, Cardiovascular; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index | 2011 |
Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Adult; Aged; Carbazoles; Carvedilol; Female; Heart; Heart Failure, Systolic; Humans; Male; Middle Aged; Propanolamines; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Time Factors; Treatment Outcome | 2010 |